Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Lyrica (pregabalin by Quarter
Lyrica (pregabalin — Upjohn spin-off to Viatris Nov 2020) [legacy] ($M) ($M)
Pfizer Lyrica (pregabalin: $352M in Q3 2020, down 33.2% from a year earlier. No newer figure appears in the documents we track.
Latest, Q3 2020
352
Period ended Sep 27, 2020
Change on a year earlier
-33.2%
527 in Q3 2019
History
14 quarters
Since Q2 2017
Sources
9
Documents cited below
Where the Q3 2020 figure comes from
Source: Form 10-Q (filed 2020-11-05) ↗
Reported in Form 10-K Segment Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Lyrica (pregabalin — Upjohn spin-off to Viatris Nov 2020) [legacy] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2020 | Sep 27, 2020 | 352 | -33.2% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 28, 2020 | 349 | -70.3% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 29, 2020 | 357 | -69.9% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2019 | Dec 31, 2019 | 433 | -67.2% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2019 | Sep 29, 2019 | 527 | -56.6% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 1,175 | -3.9% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 1,186 | -2.2% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2018 | Dec 31, 2018 | 1,321 | +5.3% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 1,213 | -5.6% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2018 | Jul 1, 2018 | 1,223 | -2.5% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2018 | Apr 1, 2018 | 1,213 | – | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2017 | Dec 31, 2017 | 1,255 | – | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2017 | Oct 1, 2017 | 1,285 | – | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2017 | Jul 2, 2017 | 1,254 | – | Form 10-Q (filed 2018-08-09) ↗ |
Cite this data
StockData. (2026). Pfizer Lyrica (pregabalin ($M), quarterly Q2 2017–Q3 2020 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/lyrica-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.